Highland Capital Management Fund Advisors, L.P. Castle Biosciences Inc Transaction History

Highland Capital Management Fund Advisors, L.P.

$846 Million
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$43.6 - $73.05 $30.8 Million - $51.6 Million	-707,032 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$15.74 - $35.04 $5.1 Million - $11.4 Million	-323,963 Reduced 31.42%	707,032 $24.3 Million
Q3 2019 Nov 14, 2019	BUY	$18.09 - $27.92 $18.7 Million - $28.8 Million	1,030,995 New	1,030,995 $18.7 Million

Others Institutions Holding CSTL

# of Institutions

205

Shares Held

26.1M

Call Options Held

303K

Put Options Held

30.3K

Black Rock Inc. New York, NY

3.04M
Shares

$84 Million
0.0% of portfolio
Wasatch Advisors Inc Salt Lake City, UT

1.83M
Shares

$50.4 Million
0.26% of portfolio
Vanguard Group Inc Valley Forge, PA

1.75M
Shares

$48.3 Million
0.0% of portfolio
Principal Financial Group Inc Des Moines, IA

1.44M
Shares

$39.6 Million
0.02% of portfolio
Bellevue Group Ag Kuesnacht, V8

1.26M
Shares

$34.8 Million
0.61% of portfolio

View Full List

About CASTLE BIOSCIENCES INC

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $726M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

More about CSTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Highland Capital Management Fund Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Highland Capital Management Fund Advisors, L.P. with notifications on news.

Account